Chantix Maker Pfizer Sponsored Quit Smoking Course Fails To Mention Chantix Side-effects
Date: 27th April 2009
According to a specific revelation, a UW online course funded by Pfizer completely ignores several side-effects yielded by the anti-smoking medicine Chantix such as blackouts, suicidal behavior and various other serious chantix side-effects. Altogether, as made apparent by sources, notwithstanding the fact that national guidelines have considered chantix to be one of the seven first-line treatments, Pfizer sponsored UW online course refers to the smoking cessation medication as the only first-line treatment therapy for smoking addiction.
Defending the accusations against the UW course, Pfizer`s spokeswoman Sally Beatty states that chantixmaker Pfizer Incl. provides informative material regarding the safe and effective use of the medicine to patients as well as doctors in specific ways and this also includes information on the package label of the medicine. She also adds that the grant provided by Pfizer to UW is not restricted and it doesn’t affect the course content.
Nevertheless, the UW course that was financed by Pfizer for doctors throughout the Wisconsin-Madison University, has been instrumental in assisting Chantix to establish its supremacy over the prescription anti-smoking market. Further, in spite of the investigation undertaken by the FDA (Food and Drugs Organization) pertaining to specific serious side-effects shown by chantix, the drug has evolved as the primary reason behind the sale of 90% anti-smoking prescriptions.
However, the amount paid for the UW course is a specific part of the $3.5 million funding provided by Pfizer and it has also been known that till now, about 140 learners that include around 100 doctors, have participated in the UW course.
Source: http://www.jsonline.com/ |
